![Linda Neuman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Linda Neuman
Keine laufenden Positionen mehr
Vermögen: 5 592 $ am 31.05.2024
Karriereverlauf von Linda Neuman
Ehemalige bekannte Positionen von Linda Neuman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SPYRE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 | 14.04.2023 |
CATALYST BIOSCIENCES | Technik-/Wissenschafts-/F&E-Leiter | - | 01.04.2021 |
ADVERUM BIOTECHNOLOGIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.10.2017 | 01.11.2018 |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - | - |
PUMA BIOTECHNOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
VIRACTA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2016 | - |
Ausbildung von Linda Neuman
Indiana Wesleyan University | Masters Business Admin |
Southern Illinois University | Undergraduate Degree |
Siu School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Operativ
Chief Tech/Sci/R&D Officer | 5 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
PUMA BIOTECHNOLOGY, INC. | Health Technology |
SPYRE THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Sunesis Pharmaceuticals, Inc.
![]() Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Catalyst Biosciences, Inc.
![]() Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Linda Neuman
- Erfahrung